KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Accumulated Expenses (2016 - 2025)

Eli Lilly's Accumulated Expenses history spans 17 years, with the latest figure at $2.4 billion for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 13.42% year-over-year to $2.4 billion; the TTM value through Dec 2025 reached $2.4 billion, up 13.42%, while the annual FY2025 figure was $2.4 billion, 13.42% up from the prior year.
  • Accumulated Expenses reached $2.4 billion in Q4 2025 per LLY's latest filing, up from $2.0 billion in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $2.4 billion in Q4 2025 to a low of $649.9 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $1.2 billion, with a median of $1.0 billion recorded in 2022.
  • Peak YoY movement for Accumulated Expenses: fell 3.92% in 2021, then soared 55.73% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $958.1 million in 2021, then increased by 10.61% to $1.1 billion in 2022, then skyrocketed by 55.73% to $1.7 billion in 2023, then rose by 26.88% to $2.1 billion in 2024, then increased by 13.42% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Accumulated Expenses are $2.4 billion (Q4 2025), $2.0 billion (Q3 2025), and $1.3 billion (Q2 2025).